Animals injected with Spn4A-expressing tumor cells exhibited a delay in tumor appearance (day 7 for HT-29/Spn4A as compared with day 2 for HT-29/CTL and day 12 for CT-26/Spn4A, as compared with day 5 for CT-26/CTL). This evidence concerns the gene DDX53 and neoplasm.